Structure–activity relationships for α‐calcitonin gene‐related peptide
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Calcitonin gene‐related peptide (CGRP) is a member of the calcitonin (CT) family of peptides. It is a widely distributed neuropeptide implicated in conditions such as neurogenic inflammation. With other members of the CT family, it shares an N‐terminal disulphide‐bonded ring which is essential for biological activity, an area of potential α‐helix, and a C‐terminal amide.CGRP binds to the calcitonin receptor‐like receptor (CLR) in complex with receptor activity‐modifying protein 1 (RAMP1), a member of the family B(or secretin‐like)GPCRs. It can also activate other CLR or calcitonin‐receptor/RAMP complexes. This 37 amino acid peptide comprises the N‐terminal ring that is required for receptor activation (residues 1–7); an α‐helix (residues 8–18), a region incorporating a β‐bend (residues 19–26) and the C‐terminal portion (residues 27–37), that is characterized by bends between residues 28–30 and 33–34. A few residues have been identified that seem to make major contributions to receptor binding and activation, with a larger number contributing either to minor interactions (which collectively may be significant), or to maintaining the conformation of the bound peptide. It is not clear if CGRP follows the pattern of other family B GPCRs in binding largely as an α‐helix. Linked Articles: This article is part of a themed section on Neuropeptides. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2013.170.issue‐7
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 9×
“CGRP also has high affinity at the AMY1 receptor, a receptor for amylin formed from the calcitonin receptor (CTR) and RAMP1 (Christopoulos et al., 1999; Poyner et al., 2002); indeed it exhibits higher potency than amylin at the receptor formed between RAMP1 and the D47 splice variant of the CTR (Qi et al., 2012).”
BackgroundInfluentialPoyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804 · cited 10×
“CGRP also has high affinity at the AMY1 receptor, a receptor for amylin formed from the calcitonin receptor (CTR) and RAMP1 (Christopoulos et al., 1999; Poyner et al., 2002); indeed it exhibits higher potency than amylin at the receptor formed between RAMP1 and the D47 splice variant of the CTR (Qi et al., 2012).”
BackgroundInfluentialSelf-citationVascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765 · cited 1×
“CGRP antagonists have attracted considerable attention for the treatment of migraine; agonists are of potential interest to treat a range of cardiovascular disorders (Brain and Grant, 2004; Durham and Vause, 2010).”
BackgroundChristopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?
Barwell, J., Gingell, J. J., Watkins, H. A., Archbold, J. K., Poyner, D. R., & Hay, D. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01525.x · Cited by 80
Self-citationNovel GLP-1 receptor agonists for diabetes
Garber, A. J. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.638282 · Cited by 69 · cited 1×
“Understanding the structure–activity relationships of natural peptides has led to the development of several stable and efficacious peptide-based agonists of family B GPCRs that have ultimately become therapeutics (Shimizu et al., 2000; Devigny et al., 2011; Garber, 2012).”
Background
Cited by
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
Russell, F. A., King, R., Smillie, S.-J., Kodji, X., & Brain, S. D. (2014) · Physiological Reviews · doi:10.1152/physrev.00034.2013 · Cited by 1,258
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Russo, A. F., & Hay, D. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00059.2021 · Cited by 382
Self-citationUpdate on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Hay, D. L., Garelja, M. L., Poyner, D. R., & Walker, C. S. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14075 · Cited by 370
Self-citationBooe, J. M., Walker, C. S., Barwell, J., Kuteyi, G., Simms, J., Jamaluddin, M. A., Warner, M. L., Bill, R. M., Harris, P. W., Brimble, M. A., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.018 · Cited by 122
Self-citationAllostery and biased agonism at class B G protein-coupled receptors
Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00049 · Cited by 112
Metadata
- Authors
- Watkins, H. A., Rathbone, D. L., Barwell, J., Hay, D. L., & Poyner, D. R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2013-11-14
- Volume
- 170
- Issue
- 7
- Pages
- 1308-1322
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2009387959
- Cited by
- 59
- References
- 6
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.